TRPV4 and Bartsocas-Papas syndrome 1: Bladder capacity, voided volume, and inter-contraction intervals significantly increased following the administration of a TRPV4 antagonist, suggesting TRPV4 is involved in urinary bladder dysfunction disorders, such as IC/BPS.